HealthQuill Pharma
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Drugs Health Pharma

Researchers find new tech to change IV therapies into oral pills

HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of.

Read More
As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before, was amplified by about 10% and its winds by 11% due to climate change.
Climate Health Pharma

Climate change amplified US Hurricane Helene’s rainfall, winds

As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before,.

Read More
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years, according to the Pan American Health Organization.
Health Medical Pharma

Dengue cases at an all-time high in Americas Region: PAHO report

Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,.

Read More
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season compared to 94.1% in the first and 64.2% in the second.
Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.

Read More
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered company has halted its trials.
Drugs Health Pharma

Sage Therapeutics halts trials of experimental drug to treat dementia

Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered.

Read More
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to a World Meteorological Organization report.
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
cigarette smoke
Drugs Health Pharma

US drug regulator clears Qnovia’s nicotine inhaler for clinical testing

HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.

Read More
More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state actors, according to a Global Witness report.
Climate Health Pharma

More than 200 land defenders died globally in 2023, Colombia deadliest

More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state.

Read More
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs Health Pharma

Johnson & Johnson stops mid-stage trial of drug for dengue prevention

Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.

Read More
Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's immune system to attack red blood cells, for an upfront $825 million.
Drugs Health Pharma

Recordati buys Sanofi’s drug for autoimmune disease for $825 million

Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's.

Read More